Pulse Biosciences (PLSE) CFO submits first ownership filing

Rhea-AI Filing Summary

PULSE BIOSCIENCES, INC. (PLSE) reported that Jon Skinner, the company’s Chief Financial Officer, has filed an initial statement of beneficial ownership on Form 3. The filing does not report any specific share holdings or transactions and notes an attached Exhibit 24 Power of Attorney.

Key Terms

Form 3, initial statement of beneficial ownership, Power of Attorney

3 terms

Form 3 regulatory

"has filed an initial statement of beneficial ownership on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

initial statement of beneficial ownership regulatory

"has filed an initial statement of beneficial ownership on Form 3"

An initial statement of beneficial ownership is the first regulatory filing an insider or large investor submits to disclose the amount of a company's stock they control or benefit from. It matters to investors because it reveals who has significant influence over a company—like showing who’s holding the cards—and helps track potential conflicts of interest, insider motives, and future buying or selling that can move the stock price.

Power of Attorney regulatory

"Exhibit 24 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

Who is the reporting person in PLSE’s latest Form 3 filing?

The reporting person is Jon Skinner, who is identified as the Chief Financial Officer of Pulse Biosciences, Inc. The Form 3 serves as his initial statement of beneficial ownership with respect to the company’s securities.

Does this PLSE Form 3 report any stock transactions by Jon Skinner?

No. The Form 3 for Jon Skinner includes no reported transactions. The transaction summary shows zero buys, sells, acquisitions, or dispositions and no derivative transactions.

Are any holdings disclosed for Jon Skinner in this PLSE Form 3?

No specific share holdings or derivative positions are disclosed. The filing’s transaction and derivative summaries show zero entries and no holding rows reported.

What role does Jon Skinner hold at Pulse Biosciences (PLSE)?

Jon Skinner is identified as an officer of Pulse Biosciences, Inc., with the title Chief Financial Officer. This role is specified in the Form 3 reporting-person information.

What additional document is referenced in this PLSE Form 3?

The Form 3 remarks reference an exhibit list that includes Exhibit 24 – Power of Attorney. This indicates a power of attorney authorizing certain actions related to SEC filings on behalf of the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 07:15 PM Accepted by SEC EDGAR 08/28/2026 - 07:14 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Skinner Jon

(Last) (First) (Middle)

C/O PULSE BIOSCIENCES, INC.

3957 POINT EDEN WAY

(Street)

HAYWARD CALIFORNIA 94545

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/03/2025

3. Issuer Name and Ticker or Trading Symbol
PULSE BIOSCIENCES, INC. [ PLSE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Kenneth B. Stratton	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)